Doherty Clinical Trials to conduct trial of Australian-developed needle-free vaccine for avian ...
Doherty Clinical Trials seeks healthy volunteers for Phase I trial of Vaxxas' needle-free avian influenza vaccine using High-Density Microarray Patch (HD-MAP) technology, which delivers vaccine to immune cells below skin surface. Previous trials showed promising results in administering seasonal influenza, COVID-19, and measles and rubella vaccines. The study, enrolling 258 participants aged 18-50, aims to assess safety and tolerability, with participants undergoing nine visits over 13 months for medical examinations and blood tests. Participants will be reimbursed for their time and expenses.
Reference News
Doherty Clinical Trials seeks healthy volunteers for Phase I trial of Vaxxas' needle-free avian influenza vaccine using High-Density Microarray Patch (HD-MAP) technology, which delivers vaccine to immune cells below skin surface. Previous trials showed promising results in administering seasonal influenza, COVID-19, and measles and rubella vaccines. The study, enrolling 258 participants aged 18-50, aims to assess safety and tolerability, with participants undergoing nine visits over 13 months for medical examinations and blood tests. Participants will be reimbursed for their time and expenses.